The expression levels of CD80 and CD86 in U937 cells co-cultured with rapamycin-pretreated cancer cells were increased compared to those of the control group, whereas, CD163 expression was decreased, in both HeLa and SiHa cell co-cultures (Fig. 2E-F). This evidence concerns the gene CD163 and cancer.